These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30467203)

  • 1. Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900.
    Fernandez HF; Sun Z; Litzow MR; Luger SM; Paietta E; Racevskis J; Levine RL; Patel JP; Abdel-Wahab O; Ketterling RP; Dewald GW; Bennett JM; Rowe JM; Lazarus HM; Tallman MS
    Haematologica; 2019 Apr; 104(4):e147-e150. PubMed ID: 30467203
    [No Abstract]   [Full Text] [Related]  

  • 2. Daunorubicin 90 mg/m
    Portugal R; Lyrio R; Loureiro M; Urago K; Bard J; Borchardt A; Garnica M; Nucci M
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):527-531. PubMed ID: 28842139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.
    Creutzig U; Zimmermann M; Bourquin JP; Dworzak MN; Fleischhack G; Graf N; Klingebiel T; Kremens B; Lehrnbecher T; von Neuhoff C; Ritter J; Sander A; Schrauder A; von Stackelberg A; Starý J; Reinhardt D
    Blood; 2013 Jul; 122(1):37-43. PubMed ID: 23704089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunorubicine in acute myelogenous leukemia in adults.
    Bornstein RS; Theologides A; Kennedy BJ
    JAMA; 1969 Feb; 207(7):1301-6. PubMed ID: 5250070
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.
    Seddon AN; Chaim J; Akin O; Drill E; Michael AG; Adel N; Tallman MS
    Leuk Res; 2018 May; 68():48-50. PubMed ID: 29544131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose versus standard-dose daunorubicin in induction therapy for young patients with de novo acute myeloid leukaemia: a meta-analysis of randomised trials.
    Su L; Zhu X; Gao S; Li W; Liu X; Tan Y
    J Chemother; 2016 Apr; 28(2):123-8. PubMed ID: 27104964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of daunorubicin in the induction therapy for adult acute myeloid leukemia.
    Usui N; Dobashi N; Kobayashi T; Yano S; Maki N; Asai O; Saito T; Yamaguchi Y; Watanabe H; Kato A; Ogihara A; Katori M; Nagamine M; Takei Y; Yamazaki H; Funakoshi S; Tajima N; Ogawa M; Kuraishi Y
    J Clin Oncol; 1998 Jun; 16(6):2086-92. PubMed ID: 9626208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escalated anthracycline dose in adult AML.
    Balakrishnan VS
    Lancet Oncol; 2017 May; 18(5):e253. PubMed ID: 28416149
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of 60 and 80 mg/m
    Vaezi M; Bahar B; Mousavi A; Yaghmai M; Kasaeian A; Souri M; Jahani M; Alimoghaddam K; Ghavamzadeh A
    Hematol Oncol; 2017 Mar; 35(1):101-105. PubMed ID: 26386260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin.
    Hui YF; Cortes JE
    Pharmacotherapy; 2000 Oct; 20(10):1221-3. PubMed ID: 11034047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
    Parovichnikova EN; Loukianova IA; Troitskaya VV; Drokov MY; Lobaova TI; Kuzmina LA; Sokolov AN; Kokhno AV; Fidarova ZT; Baskhaeva GA; Gavrilina OA; Vasilyeva VA; Obukhova TN; Kuznetsova SA; Sudarikov AB; Dvirnik VN; Galtseva IV; Davidiva JO; Kulikov SM; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):14-22. PubMed ID: 30701918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of high-dose liposomal daunorubicin (daunoxome) for refractory or relapsed acute myeloblastic leukaemia.
    Fassas A; Buffels R; Kaloyannidis P; Anagnostopoulos A
    Br J Haematol; 2003 Jul; 122(1):161-3. PubMed ID: 12823360
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of daunorubicin in induction therapy for adult acute myeloid leukemia].
    Usui N; Dobashi N; Asai O; Yano S; Kato A; Osawa H; Uno S; Katori M; Nagamine M; Yahagi Y; Yamaguchi Y; Saito T; Kasama K; Takei Y; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Ogawa M; Kuraishi Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1152-9. PubMed ID: 10945010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience.
    Dobashi N; Usui N; Yano S; Yahagi Y; Takei Y; Sugiyama K; Takahara S; Ogasawara Y; Yamaguchi Y; Saito T; Yokoyama H; Aiba K
    Jpn J Clin Oncol; 2011 Jun; 41(6):820-4. PubMed ID: 21415001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis.
    Teuffel O; Leibundgut K; Lehrnbecher T; Alonzo TA; Beyene J; Sung L
    Br J Haematol; 2013 Apr; 161(2):192-203. PubMed ID: 23398482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS; Aoki FY; Bow EJ
    J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
    Russo D; Piccaluga PP; Michieli M; Michelutti T; Visani G; Gugliotta L; Bonini A; Pierri I; Gobbi M; Tiribelli M; Fanin R; Piccolrovazzi S; Baccarani M
    Ann Hematol; 2002 Aug; 81(8):462-6. PubMed ID: 12224004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study.
    Fassas A; Buffels R; Anagnostopoulos A; Gacos E; Vadikolia C; Haloudis P; Kaloyannidis P
    Br J Haematol; 2002 Feb; 116(2):308-15. PubMed ID: 11841431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.
    Cascino GJ; Voss WB; Canaani J; Furiasse N; Rademaker A; Ky B; Luger S; Altman JK; Foran JM; Litzow MR; Tallman MS; Rigolin V; Akhter N
    Echocardiography; 2019 Nov; 36(11):2033-2040. PubMed ID: 31705570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia.
    Choi EJ; Lee JH; Lee JH; Park HS; Ko SH; Hur EH; Moon J; Goo BK; Kim Y; Seol M; Lee YS; Kang YA; Jeon M; Woo JM; Lee KH
    Leuk Res; 2018 May; 68():51-56. PubMed ID: 29544132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.